Abstract
The Novel Small Molecule Therapeutics session of the American Chemical Society 238th National Meeting and Exposition, held in Washington DC, included topics covering new therapeutic developments in CNS, anti-infective, cardiovascular and anti-inflammatory applications. This conference report highlights selected presentations on PAR2 (protease-activated receptor 2) antagonists, adenosine and P2Y receptor agonists and antagonists, antimicrobials and neuroprotective compounds.
| Original language | English |
|---|---|
| Pages (from-to) | 612-613 |
| Number of pages | 2 |
| Journal | IDrugs |
| Volume | 12 |
| Issue number | 10 |
| State | Published - Oct 2009 |